Met Life Investment Management, LLC Bei Gene, Ltd. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$221.31 - $316.61 $818,847 - $1.17 Million	-3,700 Closed	0 $0
Q3 2020 Jun 26, 2023	BUY	$189.18 - $286.44 $548,622 - $830,676	2,900 New	2,900 $830,000
Q3 2020 Nov 13, 2020	SELL	$189.18 - $286.44 $37,836 - $57,288	-200 Reduced 5.13%	3,700 $1.06 Million
Q2 2020 May 24, 2024	BUY	$123.9 - $195.41 $359,310 - $566,689	2,900 New	2,900 $546 Million
Q2 2020 Jun 26, 2023	BUY	$123.9 - $195.41 $359,310 - $566,689	2,900 New	2,900 $546,000
Q2 2020 Mar 22, 2023	BUY	$123.9 - $195.41 $61,950 - $97,705	500 Added 20.83%	2,900 $546,000
Q2 2020 Aug 14, 2020	BUY	$123.9 - $195.41 $99,120 - $156,328	800 Added 25.81%	3,900 $735,000
Q1 2020 Jul 12, 2023	BUY	$121.84 - $173.19 $292,416 - $415,656	2,400 New	2,400 $295,000
Q4 2019 Jul 12, 2023	BUY	$115.78 - $208.34 $277,872 - $500,016	2,400 New	2,400 $397,000
Q3 2019 Jul 12, 2023	BUY	$120.61 - $148.29 $289,464 - $355,896	2,400 New	2,400 $293,000
Q3 2019 Nov 14, 2019	BUY	$120.61 - $148.29 $24,122 - $29,658	200 Added 6.9%	3,100 $380,000
Q2 2019 Jul 12, 2023	BUY	$113.99 - $146.86 $273,576 - $352,464	2,400 New	2,400 $297,000
Q1 2019 Jul 13, 2023	BUY	$122.82 - $151.83 $294,768 - $364,392	2,400 New	2,400 $316,000
Q1 2019 May 15, 2019	BUY	$122.82 - $151.83 $61,410 - $75,915	500 Added 20.83%	2,900 $383,000
Q4 2018 Jul 13, 2023	BUY	$107.01 - $175.15 $256,824 - $420,360	2,400 New	2,400 $336,000
Q4 2018 Mar 22, 2023	BUY	$107.01 - $175.15 $256,824 - $420,360	2,400 New	2,400 $336,000
Q4 2018 Feb 14, 2019	BUY	$107.01 - $175.15 $256,824 - $420,360	2,400 New	2,400 $337,000

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$2.03 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.24 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$995 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$956 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$712 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.9B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account